GgoogleUS first seen 2 d ago, last 2 d ago, peak #8
Johnson & Johnson raises earnings outlook on strong drug sales
Original: jnj stock
Johnson & Johnson lifted its full-year earnings forecast after reporting a jump in quarterly pharmaceutical sales. The healthcare giant's stronger-than-expected performance from its drug business drove the raised guidance, and investors are watching how the upbeat outlook moves the company's share price in US trading.
Why now: J&J just raised its earnings outlook after strong quarterly drug sales, prompting investors to track the stock.
Evidence
- J&J Lifts Earnings Outlook After Jump in Quarterly Drug Sales · Bloomberg.com
API: https://socialmediatrends-api.osmike.com/v1/trends/2104770